Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
TOR Signaling in Growth and Metabolism
2006 Standout
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas
2007 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Heparin-Protein Interactions
2002 Standout
Mechanisms of Thrombus Formation
2008 Standout
mTOR Signaling in Growth Control and Disease
2012 Standout
The Tuberous Sclerosis Complex
2006 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Multistage Nanoparticles for Improved Delivery into Tumor Tissue
2012 StandoutNobel
Estrogen-induced Smooth Muscle Cell Growth Is Regulated by Tuberin and Associated with Altered Activation of Platelet-derived Growth Factor Receptor-β and ERK-1/2
2004
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
2012
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
2011 Standout
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
2010
Angiogenesis in health and disease
2003 Standout
PI3K signaling of autophagy is required for starvation tolerance and virulenceof Cryptococcus neoformans
2008 StandoutNobel
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Tissue factor in cancer progression and angiogenesis
2010
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
2003 StandoutNobel
The golden age: gold nanoparticles for biomedicine
2011 Standout
Phosphorylation and Functional Inactivation of TSC2 by Erk
2005 Standout
Tissue factor and angiogenesis in cancer
2002
Angiogenesis in life, disease and medicine
2005 StandoutNature
mTOR: from growth signal integration to cancer, diabetes and ageing
2010 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Systemic Lupus Erythematosus
2011 Standout
Tuberous sclerosis
2008 Standout
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering
2005 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Sickle-cell disease
2010 Standout
Thrombosis and cancer
2012
Microenvironmental regulation of metastasis
2008 Standout
Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
2003
Defining the Role of mTOR in Cancer
2007 Standout
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
2008 Standout
AKT/PKB Signaling: Navigating the Network
2017 Standout
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Mechanisms linking tumor cell-associated procoagulant function to tumor metastasis
2007
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
2006 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR
2007
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
Antiphospholipid syndrome
2010
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
2012 StandoutNobel
Update on Tumor Cell Procoagulant Factors
2001
Regulation of angiogenesis by tissue factor cytoplasmic domain signaling
2004
Molecular mechanisms of mTOR-mediated translational control
2009 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Tissue factor and PAR signaling in tumor progression
2007
Manipulating angiogenesis in medicine
2004
The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis
2007
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis
2004
Targeting of drugs and nanoparticles to tumors
2010
Protease-Activated Receptor (PAR) 2, but not PAR1, Signaling Promotes the Development of Mammary Adenocarcinoma in Polyoma Middle T Mice
2008
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Cross-talk of Integrin α3β1 and Tissue Factor in Cell Migration
2004
Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice
2012
Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin
2004
Biomimetic amplification of nanoparticle homing to tumors
2007
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies
2001
Phosphorylation of Tuberin as a Novel Mechanism for Somatic Inactivation of the Tuberous Sclerosis Complex Proteins in Brain Lesions
2004
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
2011 Standout
The Role of Iron in Diabetes and Its Complications
2007
mTOR: a pharmacologic target for autophagy regulation
2015 Standout
Identification of S664 TSC2 Phosphorylation as a Marker for Extracellular Signal-Regulated Kinase–Mediated mTOR Activation in Tuberous Sclerosis and Human Cancer
2007
Platelet-endothelial interaction in tumor angiogenesis and microcirculation
2003
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
2001
Is the Hypercoagulable State in Atrial Fibrillation Mediated by Vascular Endothelial Growth Factor?
2002
Tumor cell–associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell–dependent and–independent mechanisms
2007
Works of Katherine Casper being referenced
Regulation of Tissue Factor in Microvascular Dermal Endothelial Cells
2003
Involvement of p38 MAPK in the up‐regulation of tissue factor on endothelial cells by antiphospholipid antibodies
2005
Iron Chelators Inhibit VCAM-1 Expression in Human Dermal Microvascular Endothelial Cells
2003
Neutralization of TNF by the Antibody cA2 Reveals Differential Regulation of Adhesion Molecule Expression on TNF-Activated Endothelial Cells
1998
Tuberous sclerosis-associated neoplasms express activated p42/44 mitogen-activated protein (MAP) kinase, and inhibition of MAP kinase signaling results in decreased in vivo tumor growth.
2003
Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor
1999